{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T07:27:21Z","timestamp":1769153241574,"version":"3.49.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T00:00:00Z","timestamp":1676073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T00:00:00Z","timestamp":1676073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100694"],"award-info":[{"award-number":["82100694"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Sailing Program","award":["18YF1412700"],"award-info":[{"award-number":["18YF1412700"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The Omicron variant BA.2 was the dominant variant in the COVID-19 outbreak in Shanghai since March 2022. We aim to investigate the characteristics of SARS-CoV-2 Omicron variant infection in pediatric liver-transplanted recipients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a single-center, prospective, observational, single-arm study. We enrolled pediatric liver-transplanted patients infected with the Omicron variant BA.2 from March 19th to October 1st, 2022 and analyzed their demographic, clinical, laboratory, and outcome data. The management of COVID-19 was conducted according to the 9th trial edition of the Chinese guideline. The immunosuppressive therapy was tailored considering the patients\u2019 infection developments and liver functions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Five children were included. The primary diseases included Niemann-Pick disease, propionic acidemia, decompensated cirrhosis, biliary atresia, and Crigler-Najjar syndrome type I. All of the patients were onset with fever before or when getting RNA-positive results at the age of 3 (Range: 1\u201313) years. The infection duration was 29 (Range: 18\u201340) days. Three and two children were diagnosed with mild and moderate COVID-19 respectively. Two patients were tested RNA-positive within 14\u00a0days after having been tested negative. The immunosuppressants were paused or extenuated in four patients. Eight of all nine cohabitants were injected with at least two doses of inactivated SARS-CoV-2 vaccine. The disease courses were significantly longer than the patients (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Post-transplant immunosuppression slows down the virus clearance and increases the risk of relapse but does not affect symptom duration or infection severity in pediatric patients. Patients can usually gain a favorable outcome and prognosis by extenuating immunosuppressants.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12985-023-01978-4","type":"journal-article","created":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T08:03:58Z","timestamp":1676102638000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["SARS-CoV-2 BA.2 (Omicron) variant infection in pediatric liver transplanted recipients and cohabitants during 2022 Shanghai outbreak: a prospective cohort"],"prefix":"10.1186","volume":"20","author":[{"given":"Xin-ye","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye-feng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-xuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bi-jun","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-jun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,11]]},"reference":[{"issue":"7902","key":"1978_CR1","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41586-022-04411-y","volume":"603","author":"R Viana","year":"2022","unstructured":"Viana R, Moyo S, Amoako DG, Tegally H, Scheepers C, Althaus CL, et al. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Nature. 2022;603(7902):679\u201386. https:\/\/doi.org\/10.1038\/s41586-022-04411-y.","journal-title":"Nature"},{"issue":"10335","key":"1978_CR2","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/s0140-6736(22)00327-0","volume":"399","author":"C Menni","year":"2022","unstructured":"Menni C, Valdes AM, Polidori L, Antonelli M, Penamakuri S, Nogal A, et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet. 2022;399(10335):1618\u201324. https:\/\/doi.org\/10.1016\/s0140-6736(22)00327-0.","journal-title":"Lancet"},{"key":"1978_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac203","author":"VC Cheng","year":"2022","unstructured":"Cheng VC, Ip JD, Chu AW, Tam AR, Chan WM, Abdullah SMU, et al. Rapid spread of SARS-CoV-2 Omicron subvariant BA.2 in a single-source community outbreak. Clin Infect Dis. 2022. https:\/\/doi.org\/10.1093\/cid\/ciac203.","journal-title":"Clin Infect Dis"},{"key":"1978_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taac049","author":"Z Guo","year":"2022","unstructured":"Guo Z, Zhao S, Lee SS, Mok CKP, Wong NS, Wang J, et al. Superspreading potential of COVID-19 outbreak seeded by Omicron variants of SARS-CoV-2 in Hong Kong. J Travel Med. 2022. https:\/\/doi.org\/10.1093\/jtm\/taac049.","journal-title":"J Travel Med"},{"issue":"10340","key":"1978_CR5","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1016\/s0140-6736(22)00838-8","volume":"399","author":"X Zhang","year":"2022","unstructured":"Zhang X, Zhang W, Chen S. Shanghai\u2019s life-saving efforts against the current omicron wave of the COVID-19 pandemic. Lancet. 2022;399(10340):2011\u20132. https:\/\/doi.org\/10.1016\/s0140-6736(22)00838-8.","journal-title":"Lancet"},{"issue":"7","key":"1978_CR6","doi-asserted-by":"publisher","first-page":"238","DOI":"10.15585\/mmwr.mm7107a3","volume":"71","author":"SE Smith-Jeffcoat","year":"2022","unstructured":"Smith-Jeffcoat SE, Pomeroy MA, Sleweon S, Sami S, Ricaldi JN, Gebru Y, et al. Multistate outbreak of SARS-CoV-2 B.1.1.529 (Omicron) variant infections among persons in a social network attending a convention - New York City, November 18\u2013December 20, 2021. MMWR Morb Mortal Wkly Rep. 2022;71(7):238\u201342. https:\/\/doi.org\/10.15585\/mmwr.mm7107a3.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"14","key":"1978_CR7","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1056\/NEJMoa2119658","volume":"386","author":"SA Madhi","year":"2022","unstructured":"Madhi SA, Kwatra G, Myers JE, Jassat W, Dhar N, Mukendi CK, et al. Population immunity and Covid-19 severity with Omicron variant in South Africa. N Engl J Med. 2022;386(14):1314\u201326. https:\/\/doi.org\/10.1056\/NEJMoa2119658.","journal-title":"N Engl J Med"},{"issue":"12","key":"1978_CR8","doi-asserted-by":"publisher","first-page":"466","DOI":"10.15585\/mmwr.mm7112e2","volume":"71","author":"CA Taylor","year":"2022","unstructured":"Taylor CA, Whitaker M, Anglin O, Milucky J, Patel K, Pham H, et al. COVID-19-associated hospitalizations among adults during SARS-CoV-2 delta and omicron variant predominance, by race\/ethnicity and vaccination status - COVID-NET, 14 states, July 2021\u2013January 2022. MMWR Morb Mortal Wkly Rep. 2022;71(12):466\u201373. https:\/\/doi.org\/10.15585\/mmwr.mm7112e2.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"1978_CR9","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1002\/jmv.27613","volume":"94","author":"L Houhamdi","year":"2022","unstructured":"Houhamdi L, Gautret P, Hoang VT, Fournier PE, Colson P, Raoult D. Characteristics of the first 1119 SARS-CoV-2 Omicron variant cases, in Marseille, France, November-December 2021. J Med Virol. 2022;94(5):2290\u20135. https:\/\/doi.org\/10.1002\/jmv.27613.","journal-title":"J Med Virol"},{"issue":"5","key":"1978_CR10","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.jhep.2013.12.021","volume":"60","author":"S Fagiuoli","year":"2014","unstructured":"Fagiuoli S, Colli A, Bruno R, Crax\u00ec A, Gaeta GB, Grossi P, et al. Management of infections pre- and post-liver transplantation: report of an AISF consensus conference. J Hepatol. 2014;60(5):1075\u201389. https:\/\/doi.org\/10.1016\/j.jhep.2013.12.021.","journal-title":"J Hepatol"},{"key":"1978_CR11","doi-asserted-by":"publisher","unstructured":"Shelhamer JH, Toews GB, Masur H, Suffredini AF, Pizzo PA, Walsh TJ, et al. NIH conference. Respiratory disease in the immunosuppressed patient. Ann Intern Med. 1992;117(5):415\u201331. https:\/\/doi.org\/10.7326\/0003-4819-117-5-415.","DOI":"10.7326\/0003-4819-117-5-415"},{"issue":"1","key":"1978_CR12","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jhep.2020.07.040","volume":"74","author":"J Colmenero","year":"2021","unstructured":"Colmenero J, Rodr\u00edguez-Per\u00e1lvarez M, Salcedo M, Arias-Milla A, Mu\u00f1oz-Serrano A, Graus J, et al. Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients. J Hepatol. 2021;74(1):148\u201355. https:\/\/doi.org\/10.1016\/j.jhep.2020.07.040.","journal-title":"J Hepatol"},{"issue":"6","key":"1978_CR13","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1002\/hep.31574","volume":"72","author":"A Rabiee","year":"2020","unstructured":"Rabiee A, Sadowski B, Adeniji N, Perumalswami PV, Nguyen V, Moghe A, et al. Liver Injury in liver transplant recipients with coronavirus disease 2019 (COVID-19): U.S. multicenter experience. Hepatology. 2020;72(6):1900\u201311. https:\/\/doi.org\/10.1002\/hep.31574.","journal-title":"Hepatology"},{"issue":"3","key":"1978_CR14","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.jhep.2020.04.006","volume":"73","author":"Q Cai","year":"2020","unstructured":"Cai Q, Huang D, Yu H, Zhu Z, Xia Z, Su Y, et al. COVID-19: abnormal liver function tests. J Hepatol. 2020;73(3):566\u201374. https:\/\/doi.org\/10.1016\/j.jhep.2020.04.006.","journal-title":"J Hepatol"},{"issue":"4","key":"1978_CR15","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.jhep.2020.05.002","volume":"73","author":"Y Wang","year":"2020","unstructured":"Wang Y, Liu S, Liu H, Li W, Lin F, Jiang L, et al. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. J Hepatol. 2020;73(4):807\u201316. https:\/\/doi.org\/10.1016\/j.jhep.2020.05.002.","journal-title":"J Hepatol"},{"issue":"6","key":"1978_CR16","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.jhep.2021.08.008","volume":"75","author":"PJ Thuluvath","year":"2021","unstructured":"Thuluvath PJ, Robarts P, Chauhan M. Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases. J Hepatol. 2021;75(6):1434\u20139. https:\/\/doi.org\/10.1016\/j.jhep.2021.08.008.","journal-title":"J Hepatol"},{"issue":"1","key":"1978_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2021.07.034","volume":"76","author":"M Guarino","year":"2022","unstructured":"Guarino M, Cossiga V, Esposito I, Furno A, Morisco F. Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: the debate is open! J Hepatol. 2022;76(1):237\u20139. https:\/\/doi.org\/10.1016\/j.jhep.2021.07.034.","journal-title":"J Hepatol"},{"issue":"1","key":"1978_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jhep.2021.07.024","volume":"76","author":"H Shroff","year":"2022","unstructured":"Shroff H, Satapathy SK, Crawford JM, Todd NJ, VanWagner LB. Liver injury following SARS-CoV-2 vaccination: a multicenter case series. J Hepatol. 2022;76(1):211\u20134. https:\/\/doi.org\/10.1016\/j.jhep.2021.07.024.","journal-title":"J Hepatol"},{"issue":"7","key":"1978_CR19","doi-asserted-by":"publisher","first-page":"e14061","DOI":"10.1111\/petr.14061","volume":"25","author":"M Yuksel","year":"2021","unstructured":"Yuksel M, Akturk H, Mizikoglu O, Toroslu E, Arikan C. A single-center report of COVID-19 disease course and management in liver transplanted pediatric patients. Pediatr Transpl. 2021;25(7):e14061. https:\/\/doi.org\/10.1111\/petr.14061.","journal-title":"Pediatr Transpl"},{"issue":"6","key":"1978_CR20","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/lt.25756","volume":"26","author":"L D'Antiga","year":"2020","unstructured":"D\u2019Antiga L. Coronaviruses and immunosuppressed patients: the facts during the third epidemic. Liver Transpl. 2020;26(6):832\u20134. https:\/\/doi.org\/10.1002\/lt.25756.","journal-title":"Liver Transpl"},{"issue":"4","key":"1978_CR21","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/jpids\/piaa123","volume":"10","author":"MC Freeman","year":"2021","unstructured":"Freeman MC, Rapsinski GJ, Zilla ML, Wheeler SE. Immunocompromised seroprevalence and course of illness of SARS-CoV-2 in one pediatric quaternary care center. J Pediatric Infect Dis Soc. 2021;10(4):426\u201331. https:\/\/doi.org\/10.1093\/jpids\/piaa123.","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"8","key":"1978_CR22","doi-asserted-by":"publisher","first-page":"e13778","DOI":"10.1111\/petr.13778","volume":"24","author":"N Heinz","year":"2020","unstructured":"Heinz N, Griesemer A, Kinney J, Vittorio J, Lagana SM, Goldner D, et al. A case of an Infant with SARS-CoV-2 hepatitis early after liver transplantation. Pediatr Transpl. 2020;24(8):e13778. https:\/\/doi.org\/10.1111\/petr.13778.","journal-title":"Pediatr Transpl"},{"key":"1978_CR23","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2020-0186-SA","author":"SM Lagana","year":"2020","unstructured":"Lagana SM, De Michele S, Lee MJ, Emond JC, Griesemer AD, Tulin-Silver SA, et al. COVID-19 associated hepatitis complicating recent living donor liver transplantation. Arch Pathol Lab Med. 2020. https:\/\/doi.org\/10.5858\/arpa.2020-0186-SA.","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"1978_CR24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.arcped.2020.05.004","volume":"27","author":"A Morand","year":"2020","unstructured":"Morand A, Roquelaure B, Colson P, Amrane S, Bosdure E, Raoult D, et al. Child with liver transplant recovers from COVID-19 infection. A case report. Arch Pediatr. 2020;27(5):275\u20136. https:\/\/doi.org\/10.1016\/j.arcped.2020.05.004.","journal-title":"Arch Pediatr"},{"issue":"1","key":"1978_CR25","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12893-020-00878-6","volume":"20","author":"H Nikoupour","year":"2020","unstructured":"Nikoupour H, Kazemi K, Arasteh P, Ghazimoghadam S, Eghlimi H, Dara N, et al. Pediatric liver transplantation and COVID-19: a case report. BMC Surg. 2020;20(1):224. https:\/\/doi.org\/10.1186\/s12893-020-00878-6.","journal-title":"BMC Surg"},{"issue":"4","key":"1978_CR26","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.transproceed.2021.03.010","volume":"53","author":"M Dale","year":"2021","unstructured":"Dale M, Sogawa H, Seyedsaadat SM, Wolf DC, Bodin R, Partiula B, et al. Successful management of COVID-19 infection in 2 early post-liver transplant recipients. Transpl Proc. 2021;53(4):1175\u20139. https:\/\/doi.org\/10.1016\/j.transproceed.2021.03.010.","journal-title":"Transpl Proc"},{"issue":"6","key":"1978_CR27","doi-asserted-by":"publisher","first-page":"7003","DOI":"10.21037\/apm-20-996","volume":"10","author":"L Wei","year":"2021","unstructured":"Wei L, Liu B, Zhao Y, Chen Z. Prolonged shedding of SARS-CoV-2 in an elderly liver transplant patient infected by COVID-19: a case report. Ann Palliat Med. 2021;10(6):7003\u20137. https:\/\/doi.org\/10.21037\/apm-20-996.","journal-title":"Ann Palliat Med"},{"issue":"2","key":"1978_CR28","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.jceh.2021.07.005","volume":"12","author":"SS Jadaun","year":"2022","unstructured":"Jadaun SS, Singh SA, Madan K, Gupta S. SARS-CoV-2 infection in liver transplant recipients - immunosuppression is the silver lining? J Clin Exp Hepatol. 2022;12(2):384\u20139. https:\/\/doi.org\/10.1016\/j.jceh.2021.07.005.","journal-title":"J Clin Exp Hepatol"},{"issue":"7","key":"1978_CR29","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1111\/ajt.15941","volume":"20","author":"MR Pereira","year":"2020","unstructured":"Pereira MR, Mohan S, Cohen DJ, Husain SA, Dube GK, Ratner LE, et al. COVID-19 in solid organ transplant recipients: initial report from the US epicenter. Am J Transpl. 2020;20(7):1800\u20138. https:\/\/doi.org\/10.1111\/ajt.15941.","journal-title":"Am J Transpl"},{"issue":"7","key":"1978_CR30","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/s2468-1253(20)30125-4","volume":"5","author":"GJ Webb","year":"2020","unstructured":"Webb GJ, Moon AM, Barnes E, Barritt AS, Marjot T. Determining risk factors for mortality in liver transplant patients with COVID-19. Lancet Gastroenterol Hepatol. 2020;5(7):643\u20134. https:\/\/doi.org\/10.1016\/s2468-1253(20)30125-4.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1978_CR31","unstructured":"The Scheme for Diagnosis and Treatment of 2019 Novel Coronavirus Pneumonia (The 9th Trial Edition) In: China: National Health Commission of the People's Republic of China. 2022. http:\/\/www.nhc.gov.cn\/yzygj\/s7653p\/202203\/b74ade1ba4494583805a3d2e40093d88.shtml. Accessed 15 March 2022."},{"key":"1978_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02116-3","author":"H Zhang","year":"2022","unstructured":"Zhang H, Zang C, Xu Z, Zhang Y, Xu J, Bian J, et al. Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes. Nat Med. 2022. https:\/\/doi.org\/10.1038\/s41591-022-02116-3.","journal-title":"Nat Med"},{"issue":"11","key":"1978_CR33","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1038\/s41591-022-02051-3","volume":"28","author":"B Bowe","year":"2022","unstructured":"Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med. 2022;28(11):2398\u2013405. https:\/\/doi.org\/10.1038\/s41591-022-02051-3.","journal-title":"Nat Med"},{"issue":"2","key":"1978_CR34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41423-021-00836-z","volume":"19","author":"J Hu","year":"2022","unstructured":"Hu J, Peng P, Cao X, Wu K, Chen J, Wang K, et al. Increased immune escape of the new SARS-CoV-2 variant of concern Omicron. Cell Mol Immunol. 2022;19(2):293\u20135. https:\/\/doi.org\/10.1038\/s41423-021-00836-z.","journal-title":"Cell Mol Immunol"},{"issue":"7902","key":"1978_CR35","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41586-022-04479-6","volume":"603","author":"KPY Hui","year":"2022","unstructured":"Hui KPY, Ho JCW, Cheung MC, Ng KC, Ching RHH, Lai KL, et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. Nature. 2022;603(7902):715\u201320. https:\/\/doi.org\/10.1038\/s41586-022-04479-6.","journal-title":"Nature"},{"issue":"7902","key":"1978_CR36","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41586-022-04474-x","volume":"603","author":"B Meng","year":"2022","unstructured":"Meng B, Abdullahi A, Ferreira I, Goonawardane N, Saito A, Kimura I, et al. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature. 2022;603(7902):706\u201314. https:\/\/doi.org\/10.1038\/s41586-022-04474-x.","journal-title":"Nature"},{"issue":"4","key":"1978_CR37","doi-asserted-by":"publisher","first-page":"146","DOI":"10.15585\/mmwr.mm7104e4","volume":"71","author":"AD Iuliano","year":"2022","unstructured":"Iuliano AD, Brunkard JM, Boehmer TK, Peterson E, Adjei S, Binder AM, et al. Trends in disease severity and health care utilization during the early omicron variant period compared with previous SARS-CoV-2 high transmission periods - United States, December 2020\u2013January 2022. MMWR Morb Mortal Wkly Rep. 2022;71(4):146\u201352. https:\/\/doi.org\/10.15585\/mmwr.mm7104e4.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1978_CR38","doi-asserted-by":"publisher","first-page":"m3249","DOI":"10.1136\/bmj.m3249","volume":"370","author":"OV Swann","year":"2020","unstructured":"Swann OV, Holden KA, Turtle L, Pollock L, Fairfield CJ, Drake TM, et al. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. BMJ. 2020;370:m3249. https:\/\/doi.org\/10.1136\/bmj.m3249.","journal-title":"BMJ"},{"issue":"2","key":"1978_CR39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41577-022-00678-4","volume":"22","author":"A Sigal","year":"2022","unstructured":"Sigal A. Milder disease with Omicron: Is it the virus or the pre-existing immunity? Nat Rev Immunol. 2022;22(2):69\u201371. https:\/\/doi.org\/10.1038\/s41577-022-00678-4.","journal-title":"Nat Rev Immunol"},{"issue":"10332","key":"1978_CR40","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/s0140-6736(22)00462-7","volume":"399","author":"T Nyberg","year":"2022","unstructured":"Nyberg T, Ferguson NM, Nash SG, Webster HH, Flaxman S, Andrews N, et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet. 2022;399(10332):1303\u201312. https:\/\/doi.org\/10.1016\/s0140-6736(22)00462-7.","journal-title":"Lancet"},{"issue":"10323","key":"1978_CR41","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/s0140-6736(22)00017-4","volume":"399","author":"N Wolter","year":"2022","unstructured":"Wolter N, Jassat W, Walaza S, Welch R, Moultrie H, Groome M, et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022;399(10323):437\u201346. https:\/\/doi.org\/10.1016\/s0140-6736(22)00017-4.","journal-title":"Lancet"},{"key":"1978_CR42","doi-asserted-by":"publisher","first-page":"o859","DOI":"10.1136\/bmj.o859","volume":"376","author":"O Dyer","year":"2022","unstructured":"Dyer O. Covid-19: lockdowns spread in China as omicron tests \u201czero covid\u201d strategy. BMJ. 2022;376:o859. https:\/\/doi.org\/10.1136\/bmj.o859.","journal-title":"BMJ"},{"key":"1978_CR43","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1017\/s0950268822001601","volume":"150","author":"F Filippatos","year":"2022","unstructured":"Filippatos F, Tatsi EB, Dellis C, Koukou DM, Papagiannopoulos C, Margeli A, et al. SARS-CoV-2 seroepidemiology in paediatric population during Delta and Omicron predominance. Epidemiol Infect. 2022;150:e177. https:\/\/doi.org\/10.1017\/s0950268822001601.","journal-title":"Epidemiol Infect"},{"issue":"6","key":"1978_CR44","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3760\/cma.j.cn112140-20220423-00367","volume":"60","author":"WJ Ma","year":"2022","unstructured":"Ma WJ, Wang XS, Tian H, Zhu YF, Wei ZQ, Xu J, et al. Characteristics of SARS-CoV-2 Omicron infection in children imported from Hong Kong. Zhonghua Er Ke Za Zhi. 2022;60(6):539\u201344. https:\/\/doi.org\/10.3760\/cma.j.cn112140-20220423-00367.","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"13","key":"1978_CR45","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1001\/jama.2022.15439","volume":"328","author":"A Slomski","year":"2022","unstructured":"Slomski A. Long COVID in Children. JAMA. 2022;328(13):1288. https:\/\/doi.org\/10.1001\/jama.2022.15439.","journal-title":"JAMA"},{"issue":"2","key":"1978_CR46","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.jhep.2021.04.020","volume":"75","author":"L Rabinowich","year":"2021","unstructured":"Rabinowich L, Grupper A, Baruch R, Ben-Yehoyada M, Halperin T, Turner D, et al. Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients. J Hepatol. 2021;75(2):435\u20138. https:\/\/doi.org\/10.1016\/j.jhep.2021.04.020.","journal-title":"J Hepatol"},{"issue":"2","key":"1978_CR47","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.chom.2022.01.005","volume":"30","author":"S Cele","year":"2022","unstructured":"Cele S, Karim F, Lustig G, San JE, Hermanus T, Tegally H, et al. SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape. Cell Host Microbe. 2022;30(2):154-62.e5. https:\/\/doi.org\/10.1016\/j.chom.2022.01.005.","journal-title":"Cell Host Microbe"},{"issue":"16","key":"1978_CR48","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1001\/jama.2022.18931","volume":"328","author":"S Wulf Hanson","year":"2022","unstructured":"Wulf Hanson S, Abbafati C, Aerts JG, Al-Aly Z, Ashbaugh C, Ballouz T, et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328(16):1604\u201315. https:\/\/doi.org\/10.1001\/jama.2022.18931.","journal-title":"JAMA"},{"issue":"5","key":"1978_CR49","doi-asserted-by":"publisher","first-page":"e1391","DOI":"10.1002\/cti2.1391","volume":"11","author":"KK Saharia","year":"2022","unstructured":"Saharia KK, Husson JS, Niederhaus SV, Iraguha T, Avila SV, Yoo YJ, et al. Humoral immunity against SARS-CoV-2 variants including omicron in solid organ transplant recipients after three doses of a COVID-19 mRNA vaccine. Clin Transl Immunol. 2022;11(5):e1391. https:\/\/doi.org\/10.1002\/cti2.1391.","journal-title":"Clin Transl Immunol"},{"key":"1978_CR50","doi-asserted-by":"publisher","first-page":"103904","DOI":"10.1016\/j.ebiom.2022.103904","volume":"77","author":"Q Peng","year":"2022","unstructured":"Peng Q, Zhou R, Wang Y, Zhao M, Liu N, Li S, et al. Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong. EBioMedicine. 2022;77:103904. https:\/\/doi.org\/10.1016\/j.ebiom.2022.103904.","journal-title":"EBioMedicine"},{"issue":"1","key":"1978_CR51","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12916-022-02397-y","volume":"20","author":"B Zeng","year":"2022","unstructured":"Zeng B, Gao L, Zhou Q, Yu K, Sun F. Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis. BMC Med. 2022;20(1):200. https:\/\/doi.org\/10.1186\/s12916-022-02397-y.","journal-title":"BMC Med"},{"key":"1978_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10040556","author":"KT Lai","year":"2022","unstructured":"Lai KT, Lai Wan Loong EY, Fung TL, Luk LW, Lau CC, Zee JS, et al. Safety and immunogenicity of a booster vaccination by CoronaVac or BNT162b2 in previously two-dose inactivated virus vaccinated individuals with negative neutralizing antibody. Vaccines (Basel). 2022. https:\/\/doi.org\/10.3390\/vaccines10040556.","journal-title":"Vaccines (Basel)"},{"issue":"6600","key":"1978_CR53","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.1126\/science.abq4411","volume":"376","author":"P Elliott","year":"2022","unstructured":"Elliott P, Eales O, Steyn N, Tang D, Bodinier B, Wang H, et al. Twin peaks: the Omicron SARS-CoV-2 BA.1 and BA.2 epidemics in England. Science. 2022;376(6600):4411. https:\/\/doi.org\/10.1126\/science.abq4411.","journal-title":"Science"},{"issue":"16","key":"1978_CR54","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1001\/jama.2022.3780","volume":"327","author":"SB J\u00f8rgensen","year":"2022","unstructured":"J\u00f8rgensen SB, Nyg\u00e5rd K, Kacelnik O, Telle K. Secondary attack rates for Omicron and delta variants of SARS-CoV-2 in Norwegian households. JAMA. 2022;327(16):1610\u20131. https:\/\/doi.org\/10.1001\/jama.2022.3780.","journal-title":"JAMA"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-023-01978-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-023-01978-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-023-01978-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T13:13:26Z","timestamp":1676294006000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-023-01978-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,11]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1978"],"URL":"https:\/\/doi.org\/10.1186\/s12985-023-01978-4","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,11]]},"assertion":[{"value":"17 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None of the transplanted organ was obtained from prisoners. This study was approved by the institutional review board and ethics committee of Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University. The oral informed consent to participate in the study was obtained from each patient\u2019s parent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The written informed consent was obtained for publication of this research and any accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}